Agreement

Probi and Ipsen Sign Extensive Primary Care Distribution Agreement for …
Ipsen's commitment to oncology is exemplified through its growing portfolio of key therapies improving the care of patients suffering from prostate cancer, bladder cancer and neuro-endocrine tumors. ... Actual results may depart significantly from ... [...]
3
Like
Save
TESARO Announces Global Prostate Cancer Collaboration and Licensing Agreement …
“This innovative, indication-specific collaboration accelerates efforts to expand the treatment options available for men with prostate cancer and further increases the value of the niraparib franchise.” ... To the extent that statements contained in ... [...]
7
Like
Save
NanoString Technologies Enters Into Collaboration Agreement With Medivation …
"Triple negative breast cancer has no recognized target and standard therapy is therefore cytotoxic chemotherapy. This diagnostic has the potential to identify patients with triple negative breast cancer appropriate for treatment with enzalutamide. We ... [...]
9
Like
Save